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Summary 
A combination of immunocytochemistry, in situ hybridization and ligand binding were used to investigate 
the localization of IGF-I and its receptor in the retina of diabetic and non-diabetic BB/W-rats. Immuno- 
cytochemical localization revealed the presence of IGF-I in retinal pigment epithelium, ganglion cells, 
Muller cell processes and in microvessels. In most sites immunoreactivity was increased in the diabetic 
retina compared to that of non-diabetic BB/W-rats. In microvessels, however, immunoreactivity was 
decreased in diabetes. In situ hybridization using an antisense IGF-I riboprobe provided evidence of 
IGF-I synthesis in all retinal layers with a similar grain density in diabetic and non-diabetic rats. 
Autoradiographic localization of IGF-I receptors, using [ ‘251]-IGF-I binding, demonstrated a diffuse 
localization in all retinal layers, with an increase in diabetic animals. These findings suggest that IGF-I 
synthesis is not altered in the diabetic retina, and that the increased immunoreactivity of IGF-I detectable 
in the various layers of the retina from diabetic rats may be due to an increased uptake of blood-derived 
IGF-I suggested by increased receptor density in diabetic rats. 
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Introduction 
Trophic factors probably play a role in the patho- 
genesis of diabetic complications [ 11. In the 
diabetic retina, several trophic factors released 
into the extracellular space have been identified 
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and may be important in promoting neovascu- 
larization [ 11. A number of investigators have 
reported that insulin-like growth factor-I (IGF-I) 
expression is diminished in various tissues in ex- 
perimental diabetic rats, whereas systemic hyper- 
insulinism induced by exogenous insulin adminis- 
tration augments IGF-I expression in certain 
tissues [2-41. In clinical diabetes, however, con- 
flicting results have been obtained with respect to 
IGF-I levels in vitreous and serum from diabetic 
patients [5&j. 
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Insulin, IGF-I and -11 are present in the central 
nervous system and exhibit important effects on 
neuronal tissue growth, survival and regeneration 
[7]. Although the IGF-I gene is expressed by the 
retina [8], it is not known to what extent retinal 
IGF-I is affected by diabetes. IGF-I receptors 
have been demonstrated in the retinal pigment 
epithelium (RPE), retinal rod cells, and the neural 
retina [9-111. Moreover IGF-I binds to specific 
receptors on retina derived endothelial cells and 
pericytes and stimulates their DNA synthesis 
in vitro [ 121, which may suggest a potential role 
for IGF-I in retinal neovascularization. It is, how- 
ever, not clear to what extent retinal IGF-I repre- 
sents localized synthesis or uptake of exogenous 
blood-derived IGF-I. 
In the present communication we report on the 
presence and synthesis of IGF-I and the locali- 
zation of IGF-I receptors in the retina. Further, 
we attempt to compare the abundance of retinal 
IGF-I and its receptors in diabetic and non- 
diabetic rats. 
Materials and Methods 
Animals 
Five spontaneously diabetic male BB/W-rats with 
a diabetes duration of 3 months, and age- and 
sex-matched non-diabetic BB/W-rats were used 
in this study. (NIH Colony, Department of Pa- 
thology, University of Massachusetts. Worcester, 
MA, U.S.A.). Animals were maintained in air-fil- 
tered metabolic cages with a 12 h off and on light 
cycle and given commercial rat chow (Wayne Lab 
Blox-F-6, Wayne Feed Division, Chicago, IL, 
U.S.A.) and water ad libitum. The animals were 
monitored with respect to body weight and blood 
glucose levels as previously described [ 13,141. 
Tissue collection 
Animals were anesthetized with intraperitoneal 
sodium pentobarbital (50 mg/kg of body weight) 
and killed by whole body perfusion with 4”,/, para- 
formaldehyde in 50 mmol/l phosphate buffer 
(pH 7.4). The eyes were dissected and processed 
for paraffin embedding. Five micron thick 
sections on aminoalkylsialane coated slides were 
used for immunocytochemistry, in situ hybridiza- 
tion and autoradiographic localization of IGF-I 
receptors. 
Immunocytochemistry 
Rabbit anti-IGF-I antibody (kindly provided by 
Drs. J.J. von Wyk and L. Underwood) at a 
dilution of 1 : 100 was used for overnight incu- 
bation at 4’ C. Equally thick tissue sections were 
stained as previously described [4] by employing 
a biotin-streptavidin amplified system (Stravigen 
kit, Biogenex Laboratories, San Ramon, CA, 
U.S.A.). Negative controls included sections in- 
cubated with non-immune serum, or preabsorbed 
antiserum incubated for 24 h in 4°C with excess 
IGF-I. The experimental conditions were identi- 
cal for diabetic and control animals. 
Immunodot analysis 
Individual retinal samples from five diabetic and 
five non-diabetic animals were homogenized in 
3 vol of 5 mmol/l Tris-HCl (pH 7.4), centrifuged 
at 45,000 x g for 40 min, and the supernatants 
were collected. Two dilutions of the homogenate 
containing 10 and 40 pg of protein were applied 
to a nitrocellulose membrane with a 96-well mani- 
fold. All samples were analyzed in one assay using 
previously described techniques [ 151. Briefly, 
after blocking nonspecific proteins by incubation 
with 57; skim milk, the membranes were in- 
cubated with rabbit anti-IGF-I antibody (1 : 100 
in Tris buffered saline, pH 8.0 containing 0.02% 
Tween 20). Membranes were washed, and the 
presence of IGF-I was revealed by incubation 
with anti-IgG alkaline phosphate substrate 
(Promega, Mississauga, ONT, Canada). The 
slope of the line of best fit for the relationship 
between the optical density area (independent 
variable, determined by densitometry), and pro- 
tein concentration, (dependent variable), was de- 
termined for each sample and designated arbi- 
trary units of IGF-I immunoreactivity. 
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In situ hybridization 
Sections were deparalhnized and processed for 
in situ hybridization as previously described [ 161. 
Hybridization was performed at 45°C in a 
solution containing 50% formamide, 0.3 mmol/l 
NaCl, 20 mmol/l Tris-HCl (pH 8.0), 1 x 
Denhardt’s solution, 1 .O nmol/l EDTA, 0.005 % 
ssDNA, 0.005% poly (A), 20 mmol/l mercapto- 
ethanol, 0.05 % yeast tRNA and 10% dextran 
sulphate. Riboprobes were prepared from a tem- 
plate constructed by subcloning an IGF-I cDNA 
into the pGEM-3Z vector. T7 and Sp6 poly- 
merases were used for the generation of sense and 
antisense riboprobes [ 171. Autoradiography was 
performed using Kodak NTB2 tracking emulsion. 
Slides were exposed for 5-10 days prior to devel- 
opment of the photographic emulsion. 
(‘251J-IGF-I binding to retinal sections 
Retinal sections were deparaffinized and receptor 
localization was carried out as previously de- 
scribed [ 181 using [‘251]-IGF-I. Binding was 
achieved by the addition of 10 mmol/l HEPES 
buffer (pH 7.6) containing 0.50, bovine serum 
albumin, 0.025 y0 bacitracin, 0.0 125 Y0 N-ethyl- 
maleimide, 100 Kallikrein inhibitor unit/ml apro- 
tinin and 0.64 nmol/l(4 x lo5 cpm) [ 1251]-IGF-I. 
Excess unlabelled IGF-I (300 ng) was added to 
Fig. 1. Retinal micrographs showing IGF-I immunoreactivity in (A) non-diabetic BB-rat and (B) diabetic BB-rat. Microvessels 
from ‘A’ and ‘B’ are shown in ‘c’ and ‘D’, respectively. Note diminished immunostaining of endothelial cells in ‘D’ compared 
to ‘c’. RPE = retinal pigment epithelium, G = ganglion cell, M = Muller cell process. 
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TABLE 1 
Retinal IGF-I and IGF-I receptors 
IGF-I immunoreactivity 
(Arbitrary units) 
IGF-I mRNA* IGF-I receptors* 
Control 0.005 * 0.002 26.2 f 1.8 52.5 + 1.9 
(n = 5) ns ns P < 0.01 
Diabetic 0.010 + 0.003 21.6 f 0.4 15.3 + 5.5 
(n = 5) 
* Expressed as number of grains in a circle of 1 cm radius drawn on micrographs with a total magnification of 1600 x . 
determine nonspecific binding. After 20 h of incu- 
bation the slides were exposed to Kodak NTB 2 
emulsion and autoradiography was performed. 
Autoradiographic sections were photographed 
with a final magnification of 1600 times for quan- 
tification of grain density. Random circles of 1 cm 
radius were drawn on various retinal layers, and 
the number of grains within each circle was 
counted. Mean numbers of grains/circle from 
each layer were determined and the mean number 
of grains/circle/retina calculated. 
Statistical analysis 
Data were expressed as mean +_ SEM and ana- 
lyzed by Student’s t-test. 
Results 
Diabetic animals showed marked hyperglycemia 
(23.4 +_ 2.4 mmol/l vs 5.1 & 0.2 mmol/l in con- 
trols), polyuria, glycosuria and occasional keto- 
nuria. At death, diabetic rats weighed 
418.8 + 21.1 g vs control rats who weighed 
516.2 + 7.6 g. 
Immunocytochemistry 
In non-diabetic retinas IGF-I was localized to the 
retinal pigment epithelium (RPE), ganglion cells, 
Muller cell processes and areas opposing the 
inner and outer limiting membranes. The outer 
plexiform layer and some cells of the inner nuclear 
layer showed positive immunoreactivity. The 
Fig. 2. Autoradiographs following in situ hybridization of re- 
tina with IGF-I riboprobes from a normal rat with antisense 
probe (A) and with sense probe in (B). G = ganglion cell. 
outer nuclear layer showed no staining (Fig. 1). 
Positive staining was observed in the walls of 
retinal microvessels including both endothelial 
cells and pericytes (Fig. 1). In diabetic retinas the 
distribution of IGF-I appeared to be similar, how- 
ever, the staining intensity was increased com- 
pared to controls (Fig. 1). Retinal glial and neuro- 
nal components as well as the RPE showed in- 
creased immunoreactivity in diabetic rats, where- 
as in retinal microvessels the immunoreactivity of 
endothelial cells was diminished (Fig. 1). No 
staining was observed in sections incubated with 
non-immune serum or with preabsorbed antise- 
rum (data not shown). 
Immunodot analysis showed a nonsignificant 
doubling of IGF-I immunoreactivity in the retinal 
extracts of diabetic rats compared to that of the 
controls (Table 1). 
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In non-diabetic retinas, autoradiographic sig- 
nals following antisense IGF-I riboprobe hybridi- 
zation showed a diffuse distribution in all retinal 
layers (Fig. 2). A similar distribution was ob- 
served in diabetic retinas. Only minimal hybridi- 
zation was detected with the sense riboprobe 
(Fig. 2). Quantification of grain density revealed 
no difference between diabetic and control ani- 
mals, (Table 1). 
Specific binding of [ ‘251]-IGF-I was found in 
all retinal layers suggesting a widespread distribu- 
tion of IGF-I receptors in the retina (Fig. 3). The 
density of grains, was significantly higher in re- 
tinas of diabetic rats compared to control retinas 
(Fig. 3, Table 1). 
Fig. 3 Autoradiographs of retinas following receptor binding with [‘Z51]-IGF-I in (A) non-diabetic BB-rat and (B) diabetic rat. 




In the present study we have demonstrated the 
presence of IGF-I in the RPE, neuronal, and glial 
components of the normal retina as well as an 
increase in IGF-I immunoreactivity of these cell 
constituents in the retina of diabetic BB/W-rats. 
Surprisingly, endothelial cells of retinal capillary 
walls exhibited a decreased IGF-I immunoreac- 
tivity in diabetic rats. Composite retinal IGF-I 
was nonsignificantly increased in diabetic BB/W- 
rats. 
This distribution of IGF-I immunoreactivity in 
the retina is similar to that of insulin and the 
localization of IGF-I receptors is consistent with 
recent data describing their presence in the RPE 
and in the neural retina [ 11,19,20]. Retinal IGF-I 
receptors have characteristics similar to those of 
insulin receptors and are more concentrated in the 
non-photoreceptor region of the retina [ 2 11. 
In situ hybridization revealed a diffuse distribu- 
tion of signals suggesting IGF-I synthesis by 
Muller cells, although we cannot exclude the pos- 
sibility that IGF-I might be synthesized by other 
retinal cell components as well. Aldose reductase 
and insulin mRNA has been demonstrated in 
Muller cells [ 19,221. Since both aldose reductase 
mRNA and protein content are increased in 
diabetic rat retinas [23] and IGF-I synthesis ap- 
pears to be unchanged, these findings suggest, 
that IGF-I is not affected by an increased activity 
of the polyol pathway in the diabetic retina and 
that different mechanisms are probably involved 
in the regulation of these two genes. 
IGF-I levels are elevated in serum and the vi- 
treous from diabetic patients with proliferative 
retinopathy [ 51. Some investigators have de- 
monstrated a transient elevation of serum IGF-I 
during the early phases of neovascularization or 
during intensive insulin therapy with continuous 
subcutaneous insulin infusion [ 6,241. Increased 
IGF-I in diabetic vitreous could possibly reflect 
increased IGF-I synthesized by retina. However, 
in the present study of diabetic BB/W-rats dis- 
playing the preretinopathic stage of retinal 
changes, increased IGF-I immunoreactivity, in 
the absence of increased IGF-I mRNA suggests 
increased uptake of IGF-I, possibly facilitated by 
a defect in the blood-retinal barrier, rather than an 
increase in locally synthesized IGF-I. This hypo- 
thesis is supported by the demonstration of in- 
creased [ ‘251]-IGF-I binding in the retina of dia- 
betic BB/W-rats. In contrast, retinal microvessels 
demonstrated decreased immunoreactivity in 
diabetic BB/W-rats. How these findings, sug- 
gesting a downregulation of IGF-I receptor ac- 
tivity on diabetic retinal endothelial cells, can be 
reconciled with enhanced in vitro DNA synthesis 
by the same cells in response to IGF-I [ 121 
remains to be investigated. 
Acknowledgements 
This study was supported in part by grants from 
Medical Research Council of Canada (MT- 
10673, MA10674) and USPHS Research grant 
ROl- (DK 43884-01) to Dr. Sima. Dr. Charkra- 
barti is a recipient of a post-doctoral fellowship 
from Diabetes Canada. 
References 
Glaser, B.M. (1988) Extracellular modulating factors and 
the control of intraocular neovascularization. Arch. Oph- 
thalmol. 106, 603-607. 
Murphy, L.J. (1988) Impaired estrogen induced uterine 
insulin-like growth factor-I gene expression in the 
diabetic rat. Diabetologia 3 1, 842-847. 
Fagin, J.A., Roberts, CT., LeRoth, D. and Brown, A.T. 
(1989) Coordinate decrease of tissue insulin-like growth 
factor I posttranscriptional alternative mRNA tran- 
scripts in diabetes mellitus. Diabetes 38, 428-434. 
Murphy, L.J., Ghahary, A. and Chakrabarti, S. (1990) 
Expression of insulin-like growth factor-I in the rat aorta: 
regulation by insulin. Diabetes 39, 657-663. 
Grant, M., Russell, B., Fitzgerald, C. and Merimee, T.J. 
(1986) Insulin-like growth factors in vitreous: studies in 
control and diabetic subjects with neovascularization. 
Diabetes 35. 416-420. 
Hyer, S.L., Sharp, P.S., Brooks, R.A., Burrin, J.M. and 
Kohner, E.M. (1989) A two year follow-up study of serum 
insulin-like growth factor-I in diabetics with retinopathy. 
Metabolism 38, 586-589. 
97 
7 Baskin, D.G., Wilcox, B.J., Figlewicz, D.P. and Dorsa, 
D.M. (1988) Insulin and insulin-like growth factors in the 
CNS. Trends Neurosci. 11, 107-l 11. 
8 Danias, J. and Stylianopoulou, F. (1990) Expression of 
IGF-I and IGF-II genes in the adult rat eye. Curr. Eye 
Res. 9, 379-386. 
9 Hunt, R.C., Davis, A.A., Dewey, A. and Haskell, J. (1987) 
Transferrin and insulin-like growth factor-I receptors on 
retinal pigment epithelial cells. Invest. Ophthalmol. Vis. 
Sci. 28 (Suppl.), 225 (Abstract). 
10 Lick, Y., Spiegel, A.M. and Sagi-Eisenberg, R. (1987) 
Insulin-like growth factor I receptors in retinal rod outer 
segments. J. Biol. Chem. 262, 10259-10264. 
11 Ocrant, I., Valentino, K.L., King, M.C., Wimpy, T.H., 
Rosenfeld, R.G. and Baskin, D.G. (1989) Localization 
and structural characterization of insulin-like growth fac- 
tor receptors in mammalian retina. Endocrinology 125, 
2407-2413. 
12 King, G.L., Goodman, A.D., Buzney, S., Moses, A. and 
Kahn, C.R. (1985) Receptors and growth promoting ef- 
fects of insulin and insulin-like growth factors on cells 
from bovine retinal capillaries and aorta. J. Clin. Invest. 
75, 1028-1036. 
13 Sima, A.A.F., Bouchier, M. and Christensen, H. (1983) 
Axonal atrophy in sensory nerves of the diabetic 
BB-Wistar rat. A possible early correlate of human diabe- 
tic neuropathy. Ann. Neurol. 13, 264-272. 
14 Charkrabarti, S., Ma, N. and Sima, A.A.F. (1989) Re- 
duced number of anionic sites in association with glome- 
rular basement membrane thickening in diabetes. 
Diabetologia 32, 826-828. 
15 Ghahary, A., Luo, J., Gong, Y., Charkrabarti, S., Sima, 
A.A.F. and Murphy, L.J. (1989) Increased renal aldose 
reductase activity, immunoreactivity and mRNA in 
streptozotocin induced diabetic rats. Diabetes 38, 
1067-1071. 
16 Ghahary, A., Charkrabarti, S. and Murphy, L.J. (1990) 
Localization of sites of synthesis and action of insulin-like 
growth factor-I in the rat uterus. Mol. Endocrinol. 4, 
191-195. 
17 Murphy, L.J., Bell, G.I., Duckworth, M.L. and Friesen, 
H.G. (1987) Identification, characterization and regu- 
lation of a rat cDNA which encodes insulin-like growth 
factor-I. Endocrinology 121, 684-69 1. 
18 Ghahary, A. and Murphy, L.J. (1989) Uterine insulin-like 
growth factor-I receptors: regulation by estrogen and 
variation through the estrous cycle. Endocrinology 125, 
597-604. 
19 Das, A., Pansky, B. and Budd, C. (1987) Demonstration 
of insulin-specific mRNA in cultured rat retinal glial cells. 
Invest. Ophthalmol. Vis. Sci. 28, 1800-1810. 
20 Das, A., Pansky, B., Budd, G.C. and Kollaritis, C.R. 
(1984) Immunocytochemistry of mouse and human retina 
with antisera to insulin and S-100 protein. Curr. Eye Res. 
3, 1397-1401. 
21 Waldbig, R.J., Fletcher, R.T., Sommers, R.L. and Chader, 
G.F. (1988) IGF-I receptor in the bovine neural retina: 
structure, kinase activity and comparison with retinal 
insulin receptors. Exp. Eye. Res. 47, 587-607. 
22 Bondy, C.A. and Lightman, S.L. (1989) Developmental 
and physiological pattern of aldose reductase mRNA 
expression in lens and retina. Mol. Endocrinol. 3, 
1417-1425. 
23 Ghahary, A., Murphy, L.J., Chakrabarti, S. and Sima, 
A.A.F. (1990) The effects of insulin and aldose reductase 
(AR) inhibitor treatment on AR-expression. Diabetes 39 
(Suppl. l), 61A (Abstract). 
24 Hyer, S.L., Sharp, P.S., Sleightholm, M., Burrin, J.M. and 
Kohner, E.M. (1989) Progression of diabetic retinopathy 
and changes in serum insulin-like growth factor-I (IGF-I) 
during continuous subcutaneous insulin infusion (CSII). 
Horm. Metabol. Res. 21, 18-22. 
